Kidney involvement and renal manifestations in non‐Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients N Da'as, A Polliack, Y Cohen, G Amir, D Darmon, Y Kleinman, ... European journal of haematology 67 (3), 158-164, 2001 | 293 | 2001 |
Umbilical cord blood transplantation–how, when and for whom? Y Cohen, A Nagler Blood reviews 18 (3), 167-179, 2004 | 204 | 2004 |
Assessment of a personalized approach to predicting postprandial glycemic responses to food among individuals without diabetes H Mendes-Soares, T Raveh-Sadka, S Azulay, K Edens, Y Ben-Shlomo, ... JAMA network open 2 (2), e188102-e188102, 2019 | 180 | 2019 |
The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes Y Cohen, O Gutwein, O Garach-Jehoshua, A Bar-Haim, A Kornberg Hematology 19 (5), 286-292, 2014 | 119 | 2014 |
Multiple micro-predators controlling bacterial communities in the environment J Johnke, Y Cohen, M de Leeuw, A Kushmaro, E Jurkevitch, ... Current opinion in biotechnology 27, 185-190, 2014 | 110 | 2014 |
Phage therapy treatment of the coral pathogen Vibrio coralliilyticus Y Cohen, F Joseph Pollock, E Rosenberg, DG Bourne Microbiologyopen 2 (1), 64-74, 2013 | 100 | 2013 |
Hematopoietic stem-cell transplantation using umbilical-cord blood. Y Cohen, A Nagler Leukemia & lymphoma 44 (8), 2003 | 96 | 2003 |
Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals H Mendes-Soares, T Raveh-Sadka, S Azulay, Y Ben-Shlomo, Y Cohen, ... The American journal of clinical nutrition 110 (1), 63-75, 2019 | 90 | 2019 |
The nature of the β-peak in the loss modulus of amorphous solids Y Cohen, S Karmakar, I Procaccia, K Samwer Europhysics Letters 100 (3), 36003, 2012 | 69 | 2012 |
GPRC5D is a promising marker for monitoring the tumor load and to target multiple myeloma cells Y Cohen, O Gutwein, O Garach-Jehoshua, A Bar-Haim, A Kornberg Hematology 18 (6), 348-351, 2013 | 62 | 2013 |
Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis Y Cohen, G Amir, N Da'as, S Gillis, D Rund, A Polliack American journal of hematology 71 (1), 47-49, 2002 | 59 | 2002 |
The ecology of vegetation of Israel Y Waisel, G Pollak, Y Cohen Tel Aviv University, Tel Aviv, Israel (in Hebrew), 1978 | 56 | 1978 |
Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance Y Cohen, P Solal-Céligny, A Polliack Haematologica 88 (7), 811-823, 2003 | 54 | 2003 |
Cord blood biology and transplantation Y Cohen, A Nagler IMAJ-RAMAT GAN- 6 (1), 39-46, 2004 | 49 | 2004 |
An atlas of robust microbiome associations with phenotypic traits based on large-scale cohorts from two continents D Rothschild, S Leviatan, A Hanemann, Y Cohen, O Weissbrod, E Segal PLoS One 17 (3), e0265756, 2022 | 46 | 2022 |
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre … MA Dimopoulos, PG Richardson, NJ Bahlis, S Grosicki, M Cavo, ... The Lancet Haematology 9 (6), e403-e414, 2022 | 42 | 2022 |
Large‐cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine–rituximab‐containing regimens: natural history … Y Cohen, N Da'as, D Libster, G Amir, A Berrebi, A Polliack European journal of haematology 68 (2), 80-83, 2002 | 38 | 2002 |
Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma Y Cohen, A Polliack, O Zelig, A Goldfarb Leukemia & lymphoma 42 (6), 1405-1408, 2001 | 37 | 2001 |
Optimization of 6LiF: ZnS (Ag) scintillator light yield using GEANT4 Y Yehuda-Zada, K Pritchard, JB Ziegler, C Cooksey, K Siebein, ... Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 2018 | 35 | 2018 |
Translocation t (11; 14) in newly diagnosed patients with multiple myeloma: Is it always favorable? M Leiba, A Duek, N Amariglio, A Avigdor, N Benyamini, I Hardan, ... Genes, Chromosomes and Cancer 55 (9), 710-718, 2016 | 33 | 2016 |